STOCK TITAN

Sempra Form 4 Filings

SRE NYSE

Every Form 4 that Sempra (SRE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SRE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SRE filings page.

Rhea-AI Summary

Sempra senior vice president Lisa Larroque Alexander reported multiple common stock transactions on January 27, 2026. She acquired 700.43 shares of Sempra common stock at a reported price of $0 per share, increasing her direct holdings to 16,396.87 shares.

On the same date, she acquired an additional 965.78 shares at a reported price of $0 per share, bringing her direct ownership to 17,362.65 shares before a disposition. She then disposed of 577.2 shares at $87.11 per share, leaving her with 16,785.45 shares of Sempra common stock held directly.

Rhea-AI Summary

Sempra senior vice president Lisa Larroque Alexander reported a small change in her direct holdings of Sempra common stock. On 01/15/2026, a transaction in common stock was reported with transaction code "F" involving 10.06 shares at a price of $91.77 per share. Following this transaction, she directly beneficially owned 15,676.88 shares of Sempra common stock.

Rhea-AI Summary

Sempra Executive Vice President Justin C. Bird reported a small equity transaction in company common stock. On 01/15/2026, a transaction with code F involved 6.44 shares of Sempra common stock at a price of $91.77 per share, recorded as a disposition under his direct ownership.

After this activity, Bird’s directly held Sempra common stock totaled 19,411.71 shares. In addition, he reported indirect ownership of 4,689.07 shares of Sempra common stock through a 401(k) savings plan as of 01/15/2026.

Rhea-AI Summary

Sempra’s chief legal counsel, Diana L. Day, reported an insider transaction in the company’s common stock. On January 15, 2026, she disposed of 9.4 shares of Sempra common stock at a price of $91.77 per share, recorded under transaction code F. After this transaction, she reported owning 25,082.28 shares of Sempra common stock directly. She also reported an additional 418.61 shares held indirectly through a 401(k) Savings Plan as of January 15, 2026.

Rhea-AI Summary

Sempra Executive VP and CFO Karen L. Sedgwick reported a small disposition of company common stock. On 01/15/2026, a transaction in Sempra common stock with transaction code F covered 6.19 shares at $91.77 per share. After this activity, she held 40,336.59 shares directly and 153.61 shares indirectly through a 401(k) savings plan as of the same date. This filing provides investors with updated information on the executive’s current beneficial ownership.

Rhea-AI Summary

Sempra executive Dyan Z. Wold, VP, Controller and Chief Accounting Officer, reported a disposition of Sempra common stock. On 01/15/2026, 5.31 shares of common stock were disposed of at a price of $91.77 per share, coded as transaction type "F." After this transaction, Wold beneficially owns 5,677.36 shares of Sempra common stock, held directly.

Rhea-AI Summary

Sempra Executive Vice President Caroline A. Winn reported a transaction in Sempra common stock on January 15, 2026. The Form 4 shows a code F disposition of 16.45 shares of common stock at a price of $91.77 per share. Following this transaction, Winn directly beneficially owned 31,252.27 shares of Sempra common stock. The filing also reports an indirect holding of 11,164 shares in a 401(k) savings plan as of January 15, 2026.

Rhea-AI Summary

Sempra executive Dyan Z. Wold, Vice President, Controller and Chief Accounting Officer, reported two transactions in Sempra common stock on 01/02/2026. One transaction (code F) shows the disposition of 700.98 shares of common stock at $89.71 per share. A second transaction (code A) records the acquisition of 2,890 shares of common stock at $0 per share. Following these transactions, Wold directly beneficially owned 5,670.36 shares of Sempra common stock.

Rhea-AI Summary

Sempra executive Caroline A. Winn reported stock and option activity involving Sempra (SRE) shares. On 01/02/2026, Winn had 2,442.76 shares of Sempra common stock disposed of at $89.71 per share, leaving her with 31,221.33 shares held directly and 11,164 shares held indirectly through a 401(k) savings plan as of that date.

On the same date, she received an employee stock option grant covering 60,429 shares of Sempra common stock at an exercise price of $89.71 per share, expiring on 01/01/2036. The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date.

Rhea-AI Summary

Sempra’s Executive VP and CFO Karen L. Sedgwick reported a new equity award and related share activity. On 01/02/2026, she received an employee stock option to buy 70,418 shares of Sempra common stock at an exercise price of $89.71 per share. The option expires on 01/01/2036 and becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date.

On the same date, Sedgwick reported the disposition of 953.98 shares of common stock at $89.71 per share. Following these transactions as of 01/02/2026, she beneficially owned 40,325.59 shares of Sempra common stock directly and 153.61 shares indirectly through a 401(k) savings plan, in addition to the newly granted option.

Rhea-AI Summary

Sempra officer Lisa Larroque Alexander, SVP, Corporate Affairs and HR, reported common stock transactions dated 01/02/2026. She disposed of 1,489.96 shares of Sempra common stock at $89.71 per share and acquired 5,824 shares of common stock at a price of $0 per share on the same date. Following these transactions, she beneficially owned 15,658.88 shares of Sempra common stock, held as direct ownership.

Rhea-AI Summary

Sempra insider Diana L. Day, Chief Legal Counsel, reported stock transactions dated 01/02/2026. The filing shows a disposition of 1,407.66 shares of common stock at $89.71 per share under transaction code "F", which typically relates to shares withheld to cover taxes. On the same date, she acquired 9,364 shares of common stock at $0 per share under transaction code "A", indicating a grant or vesting of equity compensation rather than an open‑market purchase.

Following these transactions, she beneficially owns 25,061.6 shares of Sempra common stock in direct ownership and 418.61 shares held indirectly through a 401(k) Savings Plan as of 01/02/2026.

Rhea-AI Summary

Sempra executive Justin C. Bird, Executive Vice President, reported equity transactions in Sempra common stock. On 01/02/2026, he was granted an employee stock option to buy 93,349 shares of Sempra common stock at an exercise price of $89.71 per share. The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant date.

The filing also reports a disposition of 916.88 shares of common stock at $89.71 per share, reported under transaction code F, typically used for shares withheld to cover taxes. After these transactions, Bird beneficially owns 19,401.71 shares directly and 4,689.07 shares indirectly through a 401(k) savings plan as of 01/02/2026.

Rhea-AI Summary

Sempra’s chairman, CEO and president reported several open-market sales of company common stock and a large stock option grant. On 01/02/2026, he sold 2,394 and 27,606 shares of common stock at weighted average prices of $88.31 and $89.38 per share. On 01/05/2026, he sold 20,533, 2,278 and 300 shares at weighted average prices of $87.13, $87.74 and $88.93 per share. He also received an employee stock option to buy 343,856 shares of Sempra common stock at an exercise price of $89.71 per share, expiring on 01/01/2036. The option becomes exercisable in three equal annual installments beginning on the first anniversary of the grant. He also reports indirect ownership through a 401(k) savings plan as of 01/02/2026.

Rhea-AI Summary

Sempra director reports phantom stock award

Director James C. Yardley reported receiving 139.34 phantom shares of Sempra common stock as director compensation at a derivative price of $89.71 per share on 01/02/2026. These phantom shares are a form of deferred equity-based compensation that track the value of Sempra common stock on a 1-for-1 basis. Following this transaction, Yardley beneficially owned a total of 40,656.7 phantom shares.

The total phantom share balance includes 1,892.82 unvested restricted phantom shares that can be forfeited if his service as a director ends before vesting for reasons other than death, disability or removal without cause. The phantom shares that have vested are immediately exercisable, and the instrument does not have an expiration date.

Rhea-AI Summary

Sempra director Anya Weaving reported receiving phantom share-based director compensation. On 01/02/2026, she acquired 139.34 phantom shares of Sempra common stock at a derivative security price of $89.71 per phantom share. These phantom shares are convertible into Sempra common stock on a 1-for-1 basis, are immediately exercisable for vested shares, and have no stated expiration date. Following this transaction, she beneficially owns 658.51 phantom shares, held in direct form.

Rhea-AI Summary

Sempra director reports phantom stock award as compensation

Cynthia J. Warner, a director of Sempra (SRE), reported receiving 323.26 phantom shares of Sempra common stock on 01/02/2026 as director compensation. These phantom shares are a derivative security tied 1-for-1 to Sempra common stock and are priced at $89.71 per phantom share. Following this transaction, she holds 13,140.67 phantom shares directly. This total includes 1,892.82 unvested restricted phantom shares that may be forfeited if her service as a director ends before vesting, except in cases of death, disability or removal without cause.

Rhea-AI Summary

Sempra director Jack T. Taylor reported receiving additional phantom shares of Sempra common stock as part of his director compensation. On 01/02/2026, he acquired 139.34 phantom shares, with the derivative security priced at $89.71 per share. Each phantom share is convertible into one share of Sempra common stock.

After this transaction, Taylor beneficially owned 41,236.46 phantom shares in total. This amount includes 1,892.82 unvested restricted phantom shares that could be forfeited if his service as a director ends before vesting for reasons other than death, disability, or removal without cause.

Rhea-AI Summary

Kevin C. Sagara, a director of Sempra, reported changes in his deferred equity-based compensation on a Form 4. The filing details phantom shares of Sempra common stock held under the company’s deferred compensation and director compensation programs.

On 01/02/2026, phantom share transactions were reported at prices of $88.95 and $89.71 per share, each representing a right tied on a 1-for-1 basis to Sempra common stock. Following these transactions, Sagara beneficially owned 3,621.32 phantom shares in total.

The phantom shares are payable in cash and may be reallocated into alternative investment accounts. The total includes 2,044.10 unvested restricted phantom shares, which are subject to forfeiture if his service as a director ends before vesting, other than in cases of death, disability, or removal without cause.

Rhea-AI Summary

Sempra director reports phantom stock compensation

Michael N. Mears, a director of Sempra, reported receiving 139.34 phantom shares of Sempra common stock on 01/02/2026 as director compensation. These derivative securities have a conversion rate of 1-for-1 into Sempra common stock and are immediately exercisable for vested shares, with no stated expiration date.

After this transaction, Mears beneficially owns a total of 20,517.13 phantom shares. This total includes 1,892.82 unvested restricted phantom shares that may be forfeited if his service as a director ends before vesting, except in cases of death, disability, or removal without cause.

Rhea-AI Summary

Sempra director reports grant of phantom stock units as compensation. Director Richard J. Mark filed a Form 4 showing he acquired 139.34 phantom shares of Sempra common stock on 01/02/2026 as director compensation. These are derivative securities that track the value of Sempra common stock and are convertible into common stock on a 1-for-1 basis. The filing states the phantom shares are immediately exercisable for vested shares and have no expiration date. Following this transaction, Mark beneficially owned 1,717.71 phantom shares, held in direct ownership form.

Rhea-AI Summary

Sempra director reports phantom stock grant as compensation

Sempra director Jennifer M. Kirk reported receiving 139.34 phantom shares of Sempra common stock on 01/02/2026 as part of her director compensation. These phantom shares are convertible into Sempra common stock on a 1-for-1 basis, with the transaction price noted as $89.71 per share. Following this grant, she beneficially owns a total of 4,672.31 phantom shares.

The total includes 1,892.82 unvested restricted phantom shares that may be forfeited if her service as a director ends before vesting, except in cases of death, disability, or removal without cause. The phantom shares that have vested are immediately exercisable, and no expiration date applies.

Rhea-AI Summary

Sempra director Pablo A. Ferrero reported receiving derivative equity compensation tied to the company’s common stock. On 01/02/2026, he acquired 139.34 phantom shares of Sempra common stock as director compensation at a price of $89.71 per phantom share.

Each phantom share converts into Sempra common stock on a 1-for-1 basis, and the shares that have vested are immediately exercisable. Following this transaction, Ferrero beneficially owned 15,774.13 phantom shares in total in direct form, with no stated expiration date for these derivative interests.

Rhea-AI Summary

Sempra director Andres Conesa reported receiving phantom stock as compensation. On 01/02/2026, he acquired 139.34 phantom shares of Sempra common stock as director compensation at a reference price of $89.71 per share. Each phantom share is convertible into one share of Sempra common stock. After this transaction, he beneficially owns 11,310.11 derivative securities in the form of phantom shares, held in direct ownership. The phantom shares are immediately exercisable for vested amounts and have no stated expiration date.

Rhea-AI Summary

Sempra (SRE) Executive VP and CFO Karen L. Sedgwick reported an open-market sale of 7,564 shares of common stock on 11/24/2025. The shares were sold at a weighted average price of $92.29 per share, with individual sale prices ranging from $92.16 to $92.36. After this transaction, she beneficially owned 41,279.57 shares of Sempra common stock directly, and an additional 153.61 shares indirectly through a 401(k) savings plan as of 11/24/2025.

Rhea-AI Summary

Sempra (SRE) officer Dyan Z. Wold, VP, Controller and CAO, reported a stock sale on Form 4. On 11/19/2025, Wold sold 1,510 shares of Sempra common stock in an open-market transaction coded as a sale, at a weighted average price of $91.38 per share. After this transaction, Wold directly beneficially owned 3,481.34 shares of Sempra common stock. The filing notes that the actual sale prices ranged from $91.33 to $91.41, with detailed trade breakdowns available upon request.

Rhea-AI Summary

Sempra Executive Vice President Caroline A. Winn reported open-market sales of company stock. On 11/18/2025, she sold 5,500 shares of Sempra common stock at a weighted average price of $91.58 per share, and on 11/19/2025 she sold an additional 500 shares at $91.70 per share.

After these transactions, she reported beneficial ownership of 33,664.09 Sempra common shares in direct form and 11,164.01 shares held through a 401(k) savings plan as of 11/18/2025. The price on 11/18/2025 is disclosed as a weighted average, with actual sale prices ranging from $91.47 to $91.70 per share.

Rhea-AI Summary

Sempra (SRE) reported an insider transaction by its SVP, Corp Affairs and HR. On 11/07/2025, the officer sold 4,322 shares of common stock at $92.55 (Transaction Code S). After the sale, the reporting person directly beneficially owned 11,324.84 shares.

Rhea-AI Summary

Kevin C. Sagara, a director of Sempra (SRE), reported acquisition of 140.04 phantom shares of Sempra common stock on 10/01/2025 as director compensation. The filing presents a price reference of $89.26 and shows total beneficial ownership of 3,913.93 shares following the transaction. The total includes 2,029.89 unvested restricted phantom shares that are subject to forfeiture if service as a director ends before vesting except for death, disability, or removal without cause. The Form 4 was signed and filed on 10/02/2025 by an attorney-in-fact.

Rhea-AI Summary

Cynthia J. Warner, a director of Sempra (SRE), acquired 324.89 phantom shares of Sempra common stock as director compensation on 10/01/2025. The reported price per share is $89.26. Following the transaction she beneficially owns 12,728.31 shares in total, which includes 1,879.66 unvested restricted phantom shares that are forfeitable if her service terminates before vesting except for death, disability, or removal without cause. The phantom shares convert 1-for-1 to common stock, exercisable immediately for vested shares; expiration is not applicable.

Rhea-AI Summary

Jennifer M. Kirk, a director of Sempra (SRE), reported receipt of 140.04 phantom shares of Sempra common stock as director compensation on 10/01/2025. The phantom shares convert 1-for-1 into common stock and are exercisable immediately for vested shares. Following the reported transaction, Ms. Kirk beneficially owns 4,501.46 shares in total, which includes 1,879.66 unvested restricted phantom shares that may be forfeited if her service as a director ends before vesting except for death, disability, or removal without cause.

Rhea-AI Summary

Richard J. Mark, a director of Sempra (SRE), reported receipt of 140.04 phantom shares as director compensation on 10/01/2025. The phantom shares convert 1-for-1 into common stock and were acquired at a reported price of $89.26 per share. The shares that vested are exercisable immediately and there is no expiration date. After this transaction, the reporting person beneficially owns 1,567.4 shares (direct ownership). The Form 4 was signed on behalf of Mr. Mark by Sempra’s attorney-in-fact on 10/02/2025.

Rhea-AI Summary

Kevin C. Sagara, a director of Sempra (SRE), reported the sale of 14,433 shares of the company's common stock on 09/29/2025 at a price of $89.50 per share under a previously established Rule 10b5-1 trading plan dated March 19, 2025. The Form 4 shows Mr. Sagara retains a direct beneficial ownership stake following the reported transaction and also holds an indirect interest of 2,404.47 shares through a 401(k) savings plan as of 09/26/2025. The filing was signed by an attorney-in-fact on Mr. Sagara's behalf and includes a Power of Attorney exhibit.